Summary: GHK-Cu UK is a copper-binding tripeptide research compound investigated in cellular signalling, tissue remodelling and protein expression pathways within controlled laboratory environments
10: 1466 (2021) Najafzadeh M, Reynolds PD, Baumgartner A, Anderson D
Memory device: C CASE = C ommon, C ellular, A melanotic, S clerosing, E pithelioid
Dosing and Administration# GHRP-6 Dosing# Typical research dose : 100-300 mcg per administration, subcutaneous Frequency : 2-3 times daily Timing : Best administered on an empty stomach
Many complaints describe symptoms that go beyond expected transient nauseasuch as recurring vomiting, delayed gastric emptying, and episodes of severe stomach painwhich is part of why this litigation is unfolding as a coordinated proceeding